# Study Assessing the Safety and Performance of Smart Matrix®

> **NCT03742726** · NA · UNKNOWN · sponsor: **Smart Matrix Limited** · enrollment: 32 (actual)

## Conditions studied

- Basal Cell Carcinoma
- Squamous Cell Carcinoma

## Interventions

- **DEVICE:** Smart Matrix scaffold

## Key facts

- **NCT ID:** NCT03742726
- **Lead sponsor:** Smart Matrix Limited
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-12
- **Primary completion:** 2021-07
- **Final completion:** 2022-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03742726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03742726, "Study Assessing the Safety and Performance of Smart Matrix®". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03742726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*